BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

774 related articles for article (PubMed ID: 30694529)

  • 1. The role of autologous stem cell transplantation in patients with nodal peripheral T-cell lymphomas in first complete remission: Report from COMPLETE, a prospective, multicenter cohort study.
    Park SI; Horwitz SM; Foss FM; Pinter-Brown LC; Carson KR; Rosen ST; Pro B; Hsi ED; Federico M; Gisselbrecht C; Schwartz M; Bellm LA; Acosta M; Advani RH; Feldman T; Lechowicz MJ; Smith SM; Lansigan F; Tulpule A; Craig MD; Greer JP; Kahl BS; Leach JW; Morganstein N; Casulo C; Shustov AR;
    Cancer; 2019 May; 125(9):1507-1517. PubMed ID: 30694529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autologous stem cell transplantation in first complete remission may not extend progression-free survival in patients with peripheral T cell lymphomas.
    Yam C; Landsburg DJ; Nead KT; Lin X; Mato AR; Svoboda J; Loren AW; Frey NV; Stadtmauer EA; Porter DL; Schuster SJ; Nasta SD
    Am J Hematol; 2016 Jul; 91(7):672-6. PubMed ID: 27012928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors and timing of autologous stem cell transplantation for patients with peripheral T-cell lymphoma.
    Yamasaki S; Chihara D; Kim SW; Kawata T; Mizuta S; Ago H; Chou T; Yamane T; Uchiyama H; Oyake T; Miura K; Saito B; Taji H; Nakamae H; Miyamoto T; Fukuda T; Kanda J; Atsuta Y; Suzuki R
    Int J Hematol; 2019 Feb; 109(2):175-186. PubMed ID: 30430419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcome and Prospective Factor Analysis of High-dose Therapy Combined with Autologous Peripheral Blood Stem Cell Transplantation in Patients with Peripheral T-cell Lymphomas.
    Wu M; Wang X; Xie Y; Liu W; Zhang C; Ping L; Ying Z; Deng L; Zheng W; Lin N; Tu M; Song Y; Zhu J
    Int J Med Sci; 2018; 15(9):867-874. PubMed ID: 30008598
    [No Abstract]   [Full Text] [Related]  

  • 5. Current Treatment Patterns and the Role of Upfront Autologous Stem Cell Transplantation in Patients with Peripheral T-Cell Lymphoma: A Korean Nationwide, Multicenter Prospective Registry Study (CISL 1404).
    Cho H; Yoon DH; Shin DY; Koh Y; Yoon SS; Kim SJ; Do YR; Lee GW; Kwak JY; Park Y; Kim MK; Kang HJ; Yi JH; Yoo KH; Lee WS; Park BB; Jo JC; Eom HS; Kim HJ; Jeong SH; Won YW; Sohn BS; Kwon JH; Suh C; Kim WS
    Cancer Res Treat; 2023 Apr; 55(2):684-692. PubMed ID: 36596727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of up-front autologous stem-cell transplantation in peripheral T-cell lymphoma for patients in response after induction: an analysis of patients from LYSA centers.
    Fossard G; Broussais F; Coelho I; Bailly S; Nicolas-Virelizier E; Toussaint E; Lancesseur C; Le Bras F; Willems E; Tchernonog E; Chalopin T; Delarue R; Gressin R; Chauchet A; Gyan E; Cartron G; Bonnet C; Haioun C; Damaj G; Gaulard P; Fornecker L; Ghesquières H; Tournilhac O; da Silva MG; Bouabdallah R; Salles G; Bachy E
    Ann Oncol; 2018 Mar; 29(3):715-723. PubMed ID: 29253087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peripheral T-cell lymphoma: the role of hematopoietic stem cell transplantation.
    Gkotzamanidou M; Papadimitriou CA
    Crit Rev Oncol Hematol; 2014 Feb; 89(2):248-61. PubMed ID: 24075060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolonged survival of patients with peripheral T-cell lymphoma after first-line intensive sequential chemotherapy with autologous stem cell transplantation.
    Prochazka V; Faber E; Raida L; Vondrakova J; Kucerova L; Jarosova M; Indrak K; Papajik T
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2009 Mar; 153(1):63-6. PubMed ID: 19365529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinical features, treatment, and prognostic factors for peripheral T-cell lymphomas: A single-institution analysis of 240 Chinese patients.
    Chen H; Tao Y; Zhou Y; Liu P; Yang J; He X; Zhou S; Qin Y; Song Y; Gui L; Zhang C; Yang S; Shi Y
    Asia Pac J Clin Oncol; 2023 Oct; 19(5):e202-e214. PubMed ID: 35821612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes and prognostic factors in angioimmunoblastic T-cell lymphoma: final report from the international T-cell Project.
    Advani RH; Skrypets T; Civallero M; Spinner MA; Manni M; Kim WS; Shustov AR; Horwitz SM; Hitz F; Cabrera ME; Dlouhy I; Vassallo J; Pileri SA; Inghirami G; Montoto S; Vitolo U; Radford J; Vose JM; Federico M
    Blood; 2021 Jul; 138(3):213-220. PubMed ID: 34292324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Up-front autologous stem-cell transplantation in peripheral T-cell lymphoma: NLG-T-01.
    d'Amore F; Relander T; Lauritzsen GF; Jantunen E; Hagberg H; Anderson H; Holte H; Österborg A; Merup M; Brown P; Kuittinen O; Erlanson M; Østenstad B; Fagerli UM; Gadeberg OV; Sundström C; Delabie J; Ralfkiaer E; Vornanen M; Toldbod HE
    J Clin Oncol; 2012 Sep; 30(25):3093-9. PubMed ID: 22851556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term outcome of patients with peripheral T-cell lymphoma treated with first-line intensive chemotherapy followed by autologous stem cell transplantation.
    Prochazka V; Faber E; Raida L; Papajik T; Vondrakova J; Rusinakova Z; Kucerova L; Myslivecek M; Indrak K
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2011 Mar; 155(1):63-9. PubMed ID: 21475380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-dose chemotherapy and autologous stem cell transplantation for peripheral T-cell lymphoma: complete response at transplant predicts survival.
    Kim MK; Kim S; Lee SS; Sym SJ; Lee DH; Jang S; Park CJ; Chi HS; Huh J; Suh C
    Ann Hematol; 2007 Jun; 86(6):435-42. PubMed ID: 17256144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of stem cell transplantation in patients with peripheral T-cell lymphoma not otherwise specified and angioimmunoblastic T-cell lymphoma.
    Yamasaki S; Yoshida S; Kato K; Choi I; Imamura Y; Kohno K; Henzan H; Tanimoto K; Ogawa R; Suehiro Y; Miyamoto T; Eto T; Ohshima K; Akashi K; Iwasaki H;
    Int J Hematol; 2020 Jul; 112(1):74-83. PubMed ID: 32297159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autologous stem-cell transplantation as consolidation of first-line chemotherapy in patients with peripheral T-cell lymphoma: a multicenter GELTAMO/FIL study.
    García-Sancho AM; Bellei M; López-Parra M; Gritti G; Cortés M; Novelli S; Panizo C; Petrucci L; Gutiérrez A; Dlouhy I; Bastos-Oreiro M; Sancho JM; Ramírez MJ; Moraleda JM; Carrillo E; Jiménez-Ubieto AI; Jarque I; Orsucci L; García-Torres E; Montalbán C; Dodero A; Arranz R; De Las Heras N; Pascual MJ; López-Jiménez J; Spina M; Re A; De Villambrosia SG; Bobillo S; Federico M; Caballero D
    Haematologica; 2022 Nov; 107(11):2675-2684. PubMed ID: 35320921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of etoposide and ASCT on survival among patients aged <65 years with stage II to IV PTCL: a population-based cohort study.
    Brink M; Meeuwes FO; van der Poel MWM; Kersten MJ; Wondergem M; Mutsaers PGNJ; Böhmer LH; Woei-A-Jin FJSH; Visser O; Oostvogels R; Jansen PM; Plattel W; Huls GA; Vermaat JSP; Nijland M
    Blood; 2022 Sep; 140(9):1009-1019. PubMed ID: 35544601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autologous stem cell transplantation as frontline strategy for peripheral T-cell lymphoma: A single-centre experience.
    Han X; Zhang W; Zhou D; Ruan J; Duan M; Zhu T; Li J; Cai H; Cao X; Ouyang M
    J Int Med Res; 2017 Feb; 45(1):290-302. PubMed ID: 28222648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical analysis of 25 patients with aggressive peripheral T-cell lymphoma in advanced stage treated with autologous stem cell transplantation].
    Zou D; Huang W; Liu H; Fu M; Li Z; Sui W; Qi J; Zhao Y; Ru K; Han M; Qiu L
    Zhonghua Xue Ye Xue Za Zhi; 2015 Jun; 36(6):455-9. PubMed ID: 26134007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peripheral T-cell lymphomas in a large US multicenter cohort: prognostication in the modern era including impact of frontline therapy.
    Abramson JS; Feldman T; Kroll-Desrosiers AR; Muffly LS; Winer E; Flowers CR; Lansigan F; Nabhan C; Nastoupil LJ; Nath R; Goy A; Castillo JJ; Jagadeesh D; Woda B; Rosen ST; Smith SM; Evens AM
    Ann Oncol; 2014 Nov; 25(11):2211-2217. PubMed ID: 25193992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-dose therapy and autologous stem cell transplantation in peripheral T-cell lymphoma: treatment outcome and prognostic factor analysis.
    Gui L; Shi YK; He XH; Lei YH; Zhang HZ; Han XH; Zhou SY; Liu P; Yang JL; Dong M; Zhang CG; Yang S; Qin Y
    Int J Hematol; 2014 Jan; 99(1):69-78. PubMed ID: 24258711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.